Ranbaxy Gets Macrobid Generic OK, Settles UK Suit

India's Ranbaxy Laboratories has reported developments in both the UK and the U.S., receiving FDA approval to make and market a generic version of Proctor and Gamble's acute cystitis drug Macrobid in the U.S., and settling a dispute with the UK Department of Health. India's Ranbaxy Laboratories has reported developments in both the UK and the US, receiving FDA approval to make and market a generic version of Proctor and Gamble's acute cystitis drug Macrobid in the US, and settling a dispute with the UK Department of Health.

Yahoo News (http://uk.biz.yahoo.com/050404/241/ffnav.html)